Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

Completed · Phase 1

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of oxaliplatin in treating patients who have advanced cancer plus liver dysfunction.

Key facts

Study ID

NCT00005077

Run by

City of Hope Medical Center

Starts

2000-02-01

Last updated by the study team

2010-01-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Beckman Research Institute, City of Hope — Los Angeles, California, United States
• University of California Davis Cancer Center — Sacramento, California, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.